Search Results - "Amanda G. M. R. Sousa"

Mid‐ to long‐term clinical and echocardiographic outcomes after transcatheter aortic valve replacement with a new‐generation, self‐expandable system by Siqueira, Dimytri A., Simonato, Matheus, Ramos, Auristela A., Bignoto, Tiago, Le Bihan, David, Barreto, Rodrigo B. M., Senra, Tiago, Pinto, Ibraim M., Kambara, Antonio M., Santos, Magaly A., Viana, Renata, Sousa, Amanda G. M. R., Abizaid, Alexandre A. C.

“…Objectives The aim of the study was to evaluate mid‐ to late clinical and echocardiographic outcomes after transcatheter aortic valve replacement (TAVR) with…”
Get full text

Very long-term follow-up of strut apposition and tissue coverage with Biolimus A9 stents analyzed by optical coherence tomography by Staico, Rodolfo, Costa, Marco A., Chamié, Daniel, Bezerra, Hiram, Armaganijan, Luciana V., Costa, Ricardo A., Costa, José Ribamar, Siqueira, Dimytri, Centemero, Marinella, Chaves, Áurea, Tanajura, Luiz Fernando, Abizaid, Alexandre, Feres, Fausto, Sousa, J. Eduardo M. R., Sousa, Amanda G. M. R.

“…First generation drug-eluting stents (DES) are associated with reduced in-stent restenosis but significant increased risk of very late stent thrombosis (VLST)…”
Get full text

Comparison of the very long term (>1 year) outcomes of drug-eluting stents for the treatment of bare-metal and drug-eluting stent restenosis by COSTA, Jose Ribamar, SOUSA, Amanda G. M. R, MOREIRA, Adriana, ALVES DA COSTA, Ricardo, CANO, Manuel N, MALDONADO, Galo, CAMPOS, Cantídio, JARDIM, Cesar, PAVANELLO, Ricardo, SOUSA, Jose Eduardo

“…Drug-eluting stents (DES) have become the first choice to treat BMS restenosis (ISR), replacing brachytherapy and all other available percutaneous approaches…”
Get full text

Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography (OCT)-The REPAIR Trial by Silva, Guilherme Barreto Gameiro, Meneguz-Moreno, Rafael A, Costa, Ricardo, Chamié, Daniel, Dangas, George, Manica, André, Arruda, Jose Airton, Sousa, Amanda G M R, Feres, Fausto, Costa, Jr, J Ribamar

“…Although first-generation drug-eluting stent (DES) devices have effectively achieved their main goal of reducing restenosis, their safety has been limited by…”
Get more information

6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias by Armaganijan, Luciana V., MD, MHS, Staico, Rodolfo, MD, PhD, Moreira, Dalmo A.R., MD, PhD, Lopes, Renato D., MD, PhD, Medeiros, Paulo T.J., MD, PhD, Habib, Ricardo, MD, Melo Neto, Jônatas, MD, Katz, Marcelo, MD, PhD, MHS, Armaganijan, Dikran, MD, PhD, Sousa, Amanda G.M.R., MD, PhD, Mahfoud, Felix, MD, Abizaid, Alexandre, MD, PhD

“…Abstract Objectives This study aimed to assess 6-month outcomes in patients with implantable cardioverter-defibrillators (ICDs) undergoing renal sympathetic…”
Get full text

Angiographic and intravascular ultrasound findings following implantation of the Endeavor™ zotarolimus-eluting stents in patients from the real-world clinical practice by FERES, Fausto, ANDRADE, Pedro B, SOUSA, Amanda G. M. R, EDUARDO SOUSA, J, COSTA, Ricardo A, DE RIBAMAR COSTA, J, ABIZAID, Alexandre, STAICO, Rodolfo, TANAJURA, Luiz F, SIQUEIRA, Dimytri, MAIA, Julio P, LASAVE, Leandro

“…The aim of this study was to investigate the angiographic and intravascular ultrasound (IVUS) findings of the Endeavor zotarolimus-eluting stent (ZES) in…”
Get full text

Novel genes detected by transcriptional profiling from whole-blood cells in patients with early onset of acute coronary syndrome by Silbiger, Vivian N., Luchessi, André D., Hirata, Rosário D.C., Lima-Neto, Lídio G., Cavichioli, Débora, Carracedo, Angel, Brión, Maria, Dopazo, Joaquín, García-García, Francisco, dos Santos, Elizabete S., Ramos, Rui F., Sampaio, Marcelo F., Armaganijan, Dikran, Sousa, Amanda G.M.R., Hirata, Mario H.

“…Genome-wide expression analysis using microarrays has been used as a research strategy to discovery new biomarkers and candidate genes for a number of…”
Get full text

Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents by SOUSA, J. Eduardo, COSTA, Marco A, SERRUYS, Patrick W, SOUSA, Amanda G. M. R, ABIZAID, Alexandre, FERES, Fausto, SEIXAS, Ana C, TANAJURA, Luiz F, MATTOS, Luiz A, FALOTICO, Robert, JAEGER, Judith, POPMA, Jeffrey J

“…Despite the proven superiority of sirolimus-eluting stents (SESs) compared with bare stents in the first year after implantation, long-term outcomes of…”
Get full text

Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries : A quantitative coronary angiography and three-dimensional intravascular ultrasound study by SOUSA, J. Eduardo, COSTA, Marco A, FALOTICO, Robert, JAEGER, Judith, POPMA, Jeffrey J, SERRUYS, Patrick W, ABIZAID, Alexandre, ABIZAID, Andrea S, FERES, Fausto, PINTO, Ibraim M. F, SEIXAS, Ana C, STAICO, Rodolfo, MATTOS, Luiz A, SOUSA, Amanda G. M. R

“…Restenosis remains an important limitation of interventional cardiology. Therefore, we aimed to determine the safety and efficacy of sirolimus (a cell-cycle…”
Get full text

Randomized Comparison of Distal and Proximal Cerebral Protection During Carotid Artery Stenting by Cano, Manuel N., MD, PhD, Kambara, Antônio M., MD, PhD, de Cano, Silvia J.F., MD, Pezzi Portela, Luiz Antônio, MD, PhD, Paes, Ângela Tavares, PhD, Costa, J. Ribamar, MD, Abizaid, Alexandre Antônio Cunha, MD, Moreira, Samuel Martins, MD, PhD, Sousa, Amanda G.M.R., MD, PhD, Sousa, J. Eduardo Moraes Rego, MD, PhD

“…Objectives This study sought to randomly compare cerebral protection with ANGIOGUARD (Cordis Corporation, Bridgewater, New Jersey) with Mo.Ma…”
Get full text

Correlation between quantitative angiographic and intravascular ultrasound parameters in patients treated with sirolimus analogous-eluting stents by Lasave, Leandro Ignacio, Costa, J. Ribamar, Costa, Ricardo, Abizaid, Andrea, Feres, Fausto, Staico, Rodolfo, Maldonado, Galo, Mattos, Luiz A., Beraldo, Pedro, Sousa, Amanda G. M. R., Sousa, J. Eduardo, Abizaid, Alexandre

“…Despite the undeniable contribution of intravascular ultrasound (IVUS) and quantitative coronary angiography (QCA) to assess drug-eluting stent (DES)…”
Get full text

1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial by Costa, Jr, J Ribamar, Abizaid, Alexandre, Costa, Ricardo, Feres, Fausto, Tanajura, Luiz Fernando, Abizaid, Andréa, Maldonado, Galo, Staico, Rodolfo, Siqueira, Dimytri, Sousa, Amanda G M R, Bonan, Raoul, Sousa, J Eduardo

“…We sought to assess the safety and efficacy of the novel VESTAsync-eluting stent (MIV Therapeutics, Atlanta, Georgia) combining a stainless steel platform with…”
Get full text

Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes by Siqueira, Dimytri A., Abizaid, Alexandre A., Costa, Jose de Ribamar, Feres, Fausto, Mattos, Luiz A., Staico, Rodolfo, Abizaid, Andrea A., Tanajura, Luiz F., Chaves, Aurea, Centemero, Marinella, Sousa, Amanda G.M.R., Sousa, J. Eduardo M.R.

“…Aim Late-acquired incomplete stent apposition (ISA) has been documented after drug-eluting stent (DES) implantation; however, its clinical role remains…”
Get full text

Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis by Jatene, Tannas, Castro‐Filho, Antonio, Meneguz‐Moreno, Rafael A., Siqueira, Dimytri A., Abizaid, Alexandre A.C., Ramos, Auristela I.O., Arrais, Magaly, Le Bihan, David C.S., Barretto, Rodrigo B.M., Moreira, Adriana C., Sousa, Amanda G.M.R., Eduardo Sousa, J.

“…Objective We sought to compare the new transcatheter aortic valve replacement (TAVR) device ACURATE neo (ACT) with the already established CoreValve (MCV) and…”
Get full text

Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries by SOUSA, J. Eduardo, COSTA, Marco A, POPMA, Jeffrey J, SERRUYS, Patrick W, SOUSA, Amanda G. M. R, ABIZAID, Alexandre C, SEIXAS, Ana C, ABIZAID, Andrea S, FERES, Fausto, MATTOS, Luiz A, FALOTICO, Robert, JAEGER, Judith

“…The safety and efficacy of sirolimus-eluting stenting have been demonstrated, but the outcome of patients treated with this novel technology beyond the first…”
Get full text

Sirolimus-eluting stent for the treatment of in-stent restenosis: A quantitative coronary angiography and three-dimensional intravascular ultrasound study by SOUSA, J. Eduardo, COSTA, Marco A, FALOTICO, Robert, JAEGER, Judith, POPMA, Jeffrey J, SERRUYS, Patrick W, ABIZAID, Alexandre, SOUSA, Amanda G. M. R, FERES, Fausto, MATTOS, Luiz A, CENTEMERO, Marinella, MALDONADO, Galo, ABIZAID, Andrea S, PINTO, Ibraim

“…We have previously reported the safety and effectiveness of sirolimus-eluting stents for the treatment of de novo coronary lesions. The present investigation…”
Get full text

Association between left atrial strain and left ventricular diastolic function in patients with acute coronary syndrome by Fernandes, Rafael Modesto, Le Bihan, David, Vilela, Andrea A., Barretto, Rodrigo B. M., Santos, Elizabete S., Assef, Jorge E., Pedra, Simone Rolim Fontes, Sousa, Amanda G. M. R., Timerman, Ari

“…Background Left ventricular diastolic function is an important prognostic marker in acute coronary syndrome. However, classification of the dysfunction grade…”
Get full text

Early Improvement in Left Atrial Remodeling and Function after Mitral Valve Repair or Replacement in Organic Symptomatic Mitral Regurgitation Assessed by Three-Dimensional Echocardiography by Le Bihan, David C. S., Della Togna, Dorival Julio, Barretto, Rodrigo B. M., Assef, Jorge Eduardo, Machado, Lúcia Romero, Ramos, Auristela Isabel de Oliveira, Abdulmassih Neto, Camilo, Moisés, Valdir Ambrosio, Sousa, Amanda G. M. R., Campos, Orlando

“…Background Left atrial (LA) dilation is associated with worse prognosis in various clinical situations including chronic mitral regurgitation (MR). Real time…”
Get full text

Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients: Insights from the RAVEL trial by ABIZAID, Alexandre, COSTA, Marco A, WIETZE, Lindeboom, SOUSA, J. Eduardo, SERRUYS, Patrick W, MORICE, Marie-Claude, BLANCHARD, Didier, ALBERTAL, Mariano, ELTCHANINOFF, Hélèn, GUAGLIUMIE, Giulio, GEERT-JAN, Laarman, ABIZAID, Andréa S, SOUSA, Amanda G. M. R, WUELFERT, Egon

“…Patients with diabetes mellitus have less favourable outcomes after percutaneous coronary intervention (PCI) than non-diabetics. We performed a subgroup…”
Get full text

Evaluation of the Safety and Efficacy of the Novel Svelte Acrobat Integrated Delivery System via Radial Approach With 5 Fr Catheters by Devito, Fernando Stucchi, Andrade, Pedro Beraldo de, Silva, Carlos Eduardo Faria, Menezes, Maria Paula C, Abizaid, Alexandre, Costa, Jr, José de Ribamar, Costa, Ricardo A, Sousa, Amanda G M R

“…To evaluate the safety and efficacy of the Svelte Acrobat integrated delivery system (IDS) via radial approach with 5 Fr catheters. The direct stenting (DS)…”
Get more information